Cargando…

Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909]

Detalles Bibliográficos
Autores principales: Van der Moeren, N, Zwart, VF, Goderski, G, Rijkers, GT, van den Bijllaardt, W, Veenemans, J, Kluytmans, JAJW, Pas, SD, Meijer, A, Verweij, JJ, Murk, JLAN, Stohr, JJJM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631605/
https://www.ncbi.nlm.nih.gov/pubmed/34862124
http://dx.doi.org/10.1016/j.jcv.2021.105028
_version_ 1784607594303717376
author Van der Moeren, N
Zwart, VF
Goderski, G
Rijkers, GT
van den Bijllaardt, W
Veenemans, J
Kluytmans, JAJW
Pas, SD
Meijer, A
Verweij, JJ
Murk, JLAN
Stohr, JJJM
author_facet Van der Moeren, N
Zwart, VF
Goderski, G
Rijkers, GT
van den Bijllaardt, W
Veenemans, J
Kluytmans, JAJW
Pas, SD
Meijer, A
Verweij, JJ
Murk, JLAN
Stohr, JJJM
author_sort Van der Moeren, N
collection PubMed
description
format Online
Article
Text
id pubmed-8631605
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-86316052021-12-01 Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909] Van der Moeren, N Zwart, VF Goderski, G Rijkers, GT van den Bijllaardt, W Veenemans, J Kluytmans, JAJW Pas, SD Meijer, A Verweij, JJ Murk, JLAN Stohr, JJJM J Clin Virol Corrigendum Elsevier B.V. 2022-02 2021-11-30 /pmc/articles/PMC8631605/ /pubmed/34862124 http://dx.doi.org/10.1016/j.jcv.2021.105028 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Van der Moeren, N
Zwart, VF
Goderski, G
Rijkers, GT
van den Bijllaardt, W
Veenemans, J
Kluytmans, JAJW
Pas, SD
Meijer, A
Verweij, JJ
Murk, JLAN
Stohr, JJJM
Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909]
title Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909]
title_full Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909]
title_fullStr Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909]
title_full_unstemmed Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909]
title_short Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909]
title_sort corrigendum to ‘performance of the diasorin sars-cov-2 antigen detection assay on the liaison xl’ [journal of clinical virology 141 (2021) 104909]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631605/
https://www.ncbi.nlm.nih.gov/pubmed/34862124
http://dx.doi.org/10.1016/j.jcv.2021.105028
work_keys_str_mv AT vandermoerenn corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT zwartvf corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT goderskig corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT rijkersgt corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT vandenbijllaardtw corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT veenemansj corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT kluytmansjajw corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT passd corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT meijera corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT verweijjj corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT murkjlan corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909
AT stohrjjjm corrigendumtoperformanceofthediasorinsarscov2antigendetectionassayontheliaisonxljournalofclinicalvirology1412021104909